In the past week, BAX stock has gone up by 2.09%, with a monthly gain of 2.39% and a quarterly plunge of -8.76%. The volatility ratio for the week is 2.29%, and the volatility levels for the last 30 days are 2.48% for Baxter International Inc The simple moving average for the past 20 days is 2.30% for BAX’s stock, with a -4.43% simple moving average for the past 200 days.
Is It Worth Investing in Baxter International Inc (NYSE: BAX) Right Now?
Company’s 36-month beta value is 0.61.Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 2 as “overweight,” 11 as “hold,” and 1 as “sell.”
The public float for BAX is 508.69M, and currently, short sellers hold a 3.36% ratio of that floaft. The average trading volume of BAX on July 02, 2025 was 4.17M shares.
BAX) stock’s latest price update
Baxter International Inc (NYSE: BAX)’s stock price has soared by 3.14 in relation to previous closing price of 30.28. Nevertheless, the company has seen a gain of 2.09% in its stock price over the last five trading days. businesswire.com reported 2025-06-24 that DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2024 Corporate Responsibility Report. The annual report demonstrates Baxter’s commitment to transparent reporting and provides updates on the company’s 2030 Corporate Responsibility Commitment and Goals,1 which strive to create a more sustainable and responsible business model. “Baxter’s Mission to Save and Sustain Lives inspires our work every day and has remained a guiding forc.
Analysts’ Opinion of BAX
Many brokerage firms have already submitted their reports for BAX stocks, with Goldman repeating the rating for BAX by listing it as a “Buy.” The predicted price for BAX in the upcoming period, according to Goldman is $42 based on the research report published on February 26, 2025 of the current year 2025.
Barclays gave a rating of “Overweight” to BAX, setting the target price at $39 in the report published on February 20th of the current year.
BAX Trading at 2.25% from the 50-Day Moving Average
After a stumble in the market that brought BAX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.87% of loss for the given period.
Stock Fundamentals for BAX
Current profitability levels for the company are sitting at:
- -0.0 for the present operating margin
- 0.36 for the gross margin
The net margin for Baxter International Inc stands at -0.05. The total capital return value is set at -0.0. Equity return is now at value -8.96, with -2.78 for asset returns.
Based on Baxter International Inc (BAX), the company’s capital structure generated 0.59 points at debt to capital in total, while cash flow to debt ratio is standing at 0.06. The debt to equity ratio resting at 1.46. The interest coverage ratio of the stock is -0.11.
Currently, EBITDA for the company is 1.12 billion with net debt to EBITDA at 7.85. When we switch over and look at the enterprise to sales, we see a ratio of 2.23. The receivables turnover for the company is 6.54for trailing twelve months and the total asset turnover is 0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.02.
Conclusion
In a nutshell, Baxter International Inc (BAX) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
